New Zealand markets closed

  • NZX 50

    10,753.16
    -115.54 (-1.06%)
     

  • NZD/USD

    0.6162
    -0.0083 (-1.32%)
     

  • NZD/EUR

    0.5901
    -0.0052 (-0.88%)
     

  • ALL ORDS

    6,720.40
    -26.10 (-0.39%)
     

  • ASX 200

    6,539.90
    -28.20 (-0.43%)
     

  • OIL

    108.42
    +2.66 (+2.52%)
     

  • GOLD

    1,786.90
    -20.40 (-1.13%)
     

  • NASDAQ

    11,503.72
    -154.55 (-1.33%)
     

  • FTSE

    7,151.04
    -18.24 (-0.25%)
     

  • Dow Jones

    30,775.43
    -253.88 (-0.82%)
     

  • DAX

    12,766.45
    -17.32 (-0.14%)
     

  • Hang Seng

    21,859.79
    -137.10 (-0.62%)
     

  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     

  • NZD/JPY

    83.3310
    -1.3840 (-1.63%)
     

Juvenile Macular Degeneration (Stargardt Disease) Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com

·4-min read

DUBLIN, May 18, 2022--(BUSINESS WIRE)--The "Juvenile Macular Degeneration (Stargardt Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

The Pharmaceutical and Healthcare disease pipeline guide provides an overview of the Juvenile Macular Degeneration pipeline landscape.

The guide provides comprehensive information on the therapeutics under development for Juvenile Macular Degeneration (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Juvenile Macular Degeneration pipeline guide also reviews of key players involved in therapeutic development for Juvenile Macular Degeneration (Stargardt Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 7, 1, 14 and 12 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

The pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Report Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Juvenile Macular Degeneration.

  • The pipeline guide reviews pipeline therapeutics for Juvenile Macular Degeneration by companies and universities/research institutes based on information derived from company and industry-specific sources.

  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

  • The pipeline guide reviews key companies involved in Juvenile Macular Degeneration therapeutics and enlists all their major and minor projects.

  • The pipeline guide evaluates Juvenile Macular Degeneration therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

  • The pipeline guide reviews latest news related to pipeline therapeutics for Juvenile Macular Degeneration

Key Topics Covered:

Juvenile Macular Degeneration (Stargardt Disease) - Overview

Therapeutics Development

  • Pipeline Overview

  • Pipeline by Companies

  • Pipeline by Universities/Institutes

  • Products under Development by Companies

  • Products under Development by Universities/Institutes

Therapeutics Assessment

  • Assessment by Target

  • Assessment by Mechanism of Action

  • Assessment by Route of Administration

  • Assessment by Molecule Type

Companies Involved in Therapeutics Development

  • 4P-Pharma SAS

  • Alkeus Pharmaceuticals Inc

  • Alnylam Pharmaceuticals Inc

  • Alpine Biotherapeutics Corp

  • Applied Genetic Technologies Corp

  • Astellas Pharma Inc

  • Beam Therapeutics Inc

  • Belite Bio Inc

  • Biophytis SA

  • Brooklyn ImmunoTherapeutics Inc

  • Cardax Inc

  • Coave Therapeutics

  • Copernicus Therapeutics Inc

  • Curative Biotechnology Inc

  • Fera Pharmaceuticals LLC

  • Generation Bio Co

  • Grupo Ferrer Internacional SA

  • IVERIC bio Inc

  • jCyte Inc

  • Katairo GmbH

  • Kubota Vision Inc

  • Lysoclear Inc

  • Mediphage Bioceuticals Inc

  • Nanoscope Therapeutics Inc

  • Oak bay Biosciences Ltd

  • ProQR Therapeutics NV

  • Ray Therapeutics Inc

  • ReVision Therapeutics Inc

  • Saliogen Therapeutics Inc

  • Shape Therapeutics Inc

  • Spark Therapeutics Inc

  • Splice Bio SL

  • Stargazer Pharmaceuticals Inc

Juvenile Macular Degeneration (Stargardt Disease) - Drug Profiles

  • 4P-020 - Drug Profile

  • ALK-001 - Drug Profile

  • ASP-7317 - Drug Profile

  • avacincaptad pegol sodium - Drug Profile

  • BIO-201 - Drug Profile

  • CDX-301 - Drug Profile

  • CTxABCA-4 - Drug Profile

  • emixustat hydrochloride - Drug Profile

  • FAB-111 - Drug Profile

  • Gene Therapy 1 to Activate ABCA4 for Stargardt Disease - Drug Profile

  • Gene therapy for Juvenile Macular Degeneration (Stargardt Disease) - Drug Profile

  • Gene Therapy to Activate ABCA4 for Stargardt Disease - Drug Profile

  • GTSG - Drug Profile

  • Jcell - Drug Profile

  • metformin - Drug Profile

  • miniABCA4: STGD1 - Drug Profile

  • QR-1011 - Drug Profile

  • RAY-001 - Drug Profile

  • REV-0100 - Drug Profile

  • SHP-261 - Drug Profile

  • soraprazan - Drug Profile

  • STG-001 - Drug Profile

  • TFB for Dry Age-Related Macular Degeneration, Stargardt Macular Dystrophy - Drug Profile

  • tinlarebant - Drug Profile

  • VMCO-1 - Drug Profile

  • vutrisiran - Drug Profile

Juvenile Macular Degeneration (Stargardt Disease) - Dormant Projects

Juvenile Macular Degeneration (Stargardt Disease) - Product Development Milestones

Featured News & Press Releases

For more information about this report visit https://www.researchandmarkets.com/r/cmh2dx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005583/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest stories

  • Insights on the Hydrogen Generation Global Market to 2027 - by Technology, Application, Systems Type and Region

    Global Hydrogen Generation Market Global Hydrogen Generation Market Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "Hydrogen Generation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global hydrogen generation market reached a value of US$ 143 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 211 Billion by 2027, exhibiting a CAGR of 6.7% during 2021-2027. Keepin

  • My Portfolio Is Down, but I'm Less Worried for This Reason

    As of a few weeks ago, my portfolio was down 30%. Based on stock market activity since then, I'm assuming things haven't changed much. Plus, the stock market has a long history of recovering from downturns, so I'm trying to take this current one in stride.

  • Form 8.3 - Nortonlifelock Inc

    FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Sculptor Capital LP and Sculptor Capital Management Europe Limited(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries m

  • Essential Oils Market 2022 | Fragrance Sector will Dominate the Industry Revenue Share to 2030 - Here's Why

    The Global Essential Oils Market size is projected to grow from USD 22.68 Billion in 2022 to USD 37.29 Billion by 2030, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period (2022-2030).Pune, July 01, 2022 (GLOBE NEWSWIRE) -- Essential Oils Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region – Global Essential Oils Market Forecast to 2030, published by Market Data Centre, T

  • Global Terrestrial Laser Scanning Market (2022 to 2027) - Featuring 3D Digital, Autodesk and Hexagon Among Others

    Global Terrestrial Laser Scanning Market Global Terrestrial Laser Scanning Market Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "Global Terrestrial Laser Scanning Market (2022-2027) by Solution, Type, Applications, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Terrestrial Laser Scanning Market is estimated to be USD 4.2 Bn in 2022 and is projected to reach USD 6.21 Bn by 2027, growing at a

  • $7.01 Bn Global Optical Detector Market Growth with GAGR of 11.7% 2022-2028 | Rising Photodetectors use in various industry Driving the Market | Market Analysis, Emerging Trends, Demand by Vantage Market Research

    WASHINGTON, July 01, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s research study report on the Global Optical Detector Market finds that the increasing demand for safety features on smartphones, such as on-screen fingerprint readers and a visual detector that detects & verifies fingerprints, is a crucial driving factor in the growth of the Optical Detector Market in coming years. In addition, the growing demand for optical sensor technology in industrial automation and robotic solutions wi

  • This Is How Warren Buffett's Estate Will Invest 90% of His Non-Donated Portfolio

    Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) hosts its annual shareholder meeting each spring, drawing tens of thousands of investors to Omaha, Nebraska. People come from around the globe to hear CEO Warren Buffett and Vice Chairman Charlie Munger discuss everything from Berkshire's business to the broader economy. As always, Buffett imparted several pearls of financial wisdom to his fans.

  • Why This Company Could See Long-Lasting Tailwinds Despite the Bear Market

    Life sciences company Thermo Fisher Scientific (NYSE: TMO) played an instrumental role in delivering COVID-19 treatments to the world's population. With healthcare spending on the rise, Thermo Fisher is expanding its services in a bid to capture even more of the market. To help address this need, The White House released a Pandemic Preparedness Plan and hopes to increase biodefense spending.

  • LexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin

    BEVERLY, Mass., July 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the MiQLab® System for automated, multiplexing PCR-based syndromic testing in veterinary clinics, is pleased to announce that it has entered into a purchase agreement with a veterinary hospital in Wisconsin. Dr. Jack Regan, LexaGene’s CEO and Founder stated, “We are pleased to announce this sale to a veterinar

  • Is This Stock a Buy After Falling 65% in a Year?

    Carnival (NYSE: CCL) fought hard to survive the pandemic, but Wall Street has rewarded the stock with a brutal 65% haircut over the past year. Should investors buy Carnival stock while the cruise industry is still navigating troubled waters? Carnival's operations and stock went through the wringer during the pandemic; an isolated space such as a cruise ship is arguably the best environment for a virus to do its worst, so the business virtually shut down throughout the pandemic to avoid spreading the contagious virus.

  • 1 Cryptocurrency to Avoid No Matter What

    Shiba Inu (CRYPTO: SHIB), to provide an extreme example, soared more than 20,000,000% in 2021, which has to be one of, if not the single greatest one-year returns in investing history. Along the same vein as many other digital assets, however, this is the result of major speculation above anything else. Despite that monster return, Shiba Inu is now down an incredible 89% from its peak (as of June 29).

  • Space Situational Awareness Market Projected to Reach $1.8 billion by 2026

    Chicago, July 01, 2022 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™ report, the "Space Situational Awareness Market by Solution (Services, Payload Systems, and Software), Orbital Range (Near-Earth and Deep Space), End Use (Commercial, and Government & Military), Object, Capability, and Region - Forecast to 2026" is projected to grow from USD 1.5 billion in 2021 to USD 1.8 billion by 2026, at a CAGR of 4.6%. A number of countries are launching satellites for the first time using new techno

  • The Global Algae-based Animal Feed and Ingredients Market is expected to grow by $ 822.67 mn during 2022-2026, accelerating at a CAGR of 6.03% during the forecast period

    Global Algae-based Animal Feed and Ingredients Market 2022-2026 The analyst has been monitoring the algae-based animal feed and ingredients market and it is poised to grow by $ 822.New York, July 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Algae-based Animal Feed and Ingredients Market 2022-2026" - https://www.reportlinker.com/p05377661/?utm_source=GNW 67 mn during 2022-2026, accelerating at a CAGR of 6.03% during the forecast period. Our report on t

  • Outlook on the 8K Technology Global Market to 2027 - Proliferation of 5G and Increasing On-Demand Content Presents Opportunities

    Global 8K Technology Market Global 8K Technology Market Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "Global 8K Technology Market (2022-2027) by Product, Consumers, Resolution, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global 8K Technology Market is estimated to be USD 3.26 Bn in 2022 and is projected to reach USD 18.9 Bn by 2027, growing at a CAGR of 42.12%.Market dynamics are forces that imp

  • FLSmidth to deliver process technology for greenfield cement plant in Asia

    FLSmidth has won a contract to supply a series of state-of-art equipment for a greenfield cement plant in Asia. The order is valued at more than DKK 400 million and has been booked in Q2 2022. The equipment will be supplied during 2023. The contract includes among other technologies; the FLSmidth OKTM Raw Mill, OKTM Cement Mill and Low NOx ILC preheater, which are flagships in FLSmidth’s MissionZero programme for Cement. "This project showcases FLSmidth’s ability to deliver energy efficient tech

  • This Dividend Beast Trades at Less Than 8 Times Earnings

    With the market now in bear territory, it's a good time to look for stocks trading at a discount, because over the long term you are likely to see good stocks recover relatively quickly and continue to appreciate. Long known as a company with volatile and inconsistent earnings, the investment banking giant Goldman Sachs (NYSE: GS) has raised its quarterly dividend a ton since 2019 and now boasts an attractive yield for dividend investors. Goldman hasn't always been known as a dividend stock, but with its latest announced increase, which isn't reflected in the chart above, the bank plans to raise its quarterly dividend from $2 per share to $2.50 starting in the third quarter.

  • Ukraine protests Russian film screening at Czech film fest

    An international film festival in the Czech spa town of Karlovy Vary kicked off Friday amid controversy following a protest by Ukraine over the screening of a Russian film alongside Ukrainian-made movies. Prior to the start of the 56th edition of the festival, several leading Ukrainian filmmakers along with Ukraine’s ambassador to Prague protested the scheduled screening of “Captain Volkonogov Escaped.” Ukrainian Ambassador Yevhen Perebyinis said in an open letter that it would be “inhuman" to screen Ukrainian films alongside a Russian movie made with support from Russia's Culture Ministry at a time when Russian troops had “committed atrocities" during their invasion of his country.

  • Stock market news lives updates: Stock futures fall as July begins with more selling

    US stock futures fell Friday morning, extending this week's losses and kicking off the first session of July with more selling.

  • Should You Investigate FedEx Corporation (NYSE:FDX) At US$227?

    FedEx Corporation ( NYSE:FDX ) saw a decent share price growth in the teens level on the NYSE over the last few months...

  • The Global Wooden Furniture Market is expected to grow by $ 49.3 bn during 2022-2026, accelerating at a CAGR of 2.73% during the forecast period

    Global Wooden Furniture Market 2022-2026 The analyst has been monitoring the wooden furniture market and it is poised to grow by $ 49. 3 bn during 2022-2026, accelerating at a CAGR of 2.New York, July 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Wooden Furniture Market 2022-2026" - https://www.reportlinker.com/p05442841/?utm_source=GNW 73% during the forecast period. Our report on the wooden furniture market provides a holistic analysis, market size a